General Information of Drug Formulation (ID: F23352)

Formulation Name
Niraparib Tosylate 100mg capsule
Company
Glaxosmithkline
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
MK-4827 DMLYGH4 Ovarian cancer 2C73 Phase 3
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Ammonia E00007 222 Alkalizing agent
Butyl alcohol E00011 263 Flavoring agent; Solvent
Erythrosine sodium anhydrous E00324 27872 Colorant
Ethanol E00023 702 Antimicrobial preservative; Penetration agent; Solvent
FD&C blue no. 1 E00263 19700 Colorant
FD&C yellow no. 5 free acid E00246 16014 Colorant
Ferric oxide black E00522 16211978 Colorant
Gelatin E00630 Not Available Other agent
Isopropyl alcohol E00070 3776 Antimicrobial preservative; Solvent
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Potassium hydroxide E00233 14797 Alkalizing agent
Propylene glycol E00040 1030 Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Shellac E00695 Not Available Coating agent; Film/membrane-forming agent; Microencapsulating agent; Modified-release agent
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Water E00035 962 Solvent